Milestone Pharmaceuticals share price logo

Milestone Pharmaceuticals

NASDAQ: MIST

$0.78

-0.03

(-3.74%)

as on

Milestone Pharmaceuticals Stock Performance

as on October 6, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.77
    $0.82
    downward going graph

    1.21%

    Downside

    5.21%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.75
    $3.06
    downward going graph

    3.50%

    Downside

    292.61%

    Upside

    downward going graph

Milestone Pharmaceuticals share price movements today

Previous Close
$0.81
Open
$0.82
Volume
1.3M
Market Cap
$100.8M
Day's Low - High
$0.77 - $0.82
52 Week Low - High
$0.75 - $3.06

Milestone Pharmaceuticals Historical Returns

1 Month Return
-35.05 %
3 Month Return
-40.95 %
1 Year Return
-63.24 %
3 Year Return
-74.02 %
5 Year Return
-86.4 %

Milestone Pharmaceuticals Stock Fundamentals & Key Indicators

Check Milestone Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$100.8M

EPS (TTM)

-0.69

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.17

Industry PE ratio

-3.20

PEG Ratio

-0.06

EBITDA

-73.2M

Revenue (TTM)

2.3M

Profit Margin

94.58%

Return On Equity TTM

-288.36%

Milestone Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Milestone Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$100.8M-86.40%-1.1794.58%0.00%
StrongBuy$44.3B650.56%-23.320.00%0.00%
Neutral$75.9B-32.81%-23.81-12.57%0.00%
StrongBuy$127.9B178.32%29.1486.04%0.00%
Buy$75.7B32.91%17.5584.86%0.50%

Stock Returns calculator for Milestone Pharmaceuticals Stock including INR - Dollar returns

The Milestone Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Milestone Pharmaceuticals investment value today

Current value as on today

₹39,902

Returns

-₹60,098

(-60.1%)

Returns from Milestone Pharmaceuticals Stock

-₹63,236 (-63.24%)

Dollar Impact

₹3,137 (+3.14%)

Analyst Recommendation on Milestone Pharmaceuticals Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Milestone Pharmaceuticals. Average target price of $5.86

Milestone Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Milestone Pharmaceuticals.

What analysts predicted

86.7%UPSIDE

Target Price

$5.86

Current Price

$0.7794

Analyzed by

2 Analysts

High

$8

Target

$5.86

Low

$7

Milestone Pharmaceuticals target price $5.86, a slight upside of 86.7% compared to current price of $0.7794. According to 2 analysts rating.

Indian Investors' Interest in Milestone Pharmaceuticals Stock

Search interest for Milestone Pharmaceuticals Stock has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-40% versus previous 30 day period

Milestone Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
1
0
0
Gross Profit
-
-
-
-
-
-
0
1
0
0
Operating Income
-10
-9
-9
-12
-20
-12
-11
-17
-23
-25
EBITDA
-9
-8
-8
-11
-19
-11
-11
-16
-21
-23
Interest Expense
0
0
0
0
0
0
0
0
4
4
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-10
-9
-9
-12
-20
-12
-11
-17
-26
-28
Income Tax Expense
-
-
-
-
-
-
0
-
0
-
Net Income
-10
-9
-9
-12
-20
-12
-11
-17
-26
-28
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
70.59%
94.28%

Milestone Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
15
5
1
-
1
Gross Profit
-
0
-
-
15
5
1
-
1
Operating Income
-8
-23
-57
-50
-43
-59
-61
-42
-62
EBITDA
-8
-23
-57
-50
-42
-58
-57
-37
-59
Interest Expense
-
-
2
0
-
-
2
-3
3
Depreciation
-
0
0
0
0
0
0
0
0
Income Before Tax
-8
-23
55
-49
-42
-58
-59
-41
-63
Income Tax Expense
0
0
0
0
-
-
-
-
0
Net Income
-8
-23
-55
-49
-42
-58
-59
-41
-63
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
100.00%
100.00%
100.00%
0.00%
92.63%

Milestone Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-10
-9
-9
-12
-20
-12
-11
-17
-26
-28
Operating Cash Flow
-8
-6
-7
-6
-13
-12
-9
-12
-16
-22
Investing Cash Flow
-27
9
6
19
33
9
-35
2
-80
111
Financing Cash Flow
32
0
0
0
0
0
49
36
94
8
Change in Cash
-3
3
0
12
19
-2
4
26
-1
98

Milestone Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-8
-23
-55
-49
-42
-58
-59
-41
-63
Operating Cash Flow
-8
-21
-51
-50
-33
-52
-46
-28
-49
Investing Cash Flow
-16
15
0
-70
70
-57
4
8
11
Financing Cash Flow
30
80
85
73
5
3
47
32
85
Change in Cash
6
75
33
-47
41
-106
6
11
47

Global Institutional Holdings in Milestone Pharmaceuticals

Check out the Institutions with significant holdings in Milestone Pharmaceuticals.

Funds
Holdings
Simplify
2.69%
Kenneth Tropin
0.11%
Fidelity Concord Street Trust
0.06%
State Street
0.02%

Milestone Pharmaceuticals News & Key Events

  • img

    Today's Timeline - 03 September

    Fri, 04:22 AM

    -

    Milestone Pharmaceuticals receives China approval for etripamil nasal spray, triggering a $2 million milestone payment.

Insights on Milestone Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 238.0K → 559.0K (in $), with an average increase of 57.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 637.9% return, outperforming this stock by 701.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 95.6% return, outperforming this stock by 169.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, MIST stock has moved down by -35.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, -11.92M → -28.61M (in $), with an average decrease of 35.2% per quarter

About Milestone Pharmaceuticals

Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etripamil, an innovative channel blocker, is currently in advanced clinical development. It is undergoing Phase III trials for the treatment of paroxysmal supraventricular tachycardia (PSVT) in the United States and Canada, while also progressing through Phase II trials for atrial fibrillation and rapid ventricular rate. Furthermore, Milestone Pharmaceuticals has forged a licensing and collaboration alliance with Ji Xing Pharmaceuticals to advance and distribute etripamil for both preventative and therapeutic applications in humans. The company was founded in 2003.
OrganisationMilestone Pharmaceuticals
Headquarters1111 Dr. Frederik-Philips Boulevard, Montreal, QC, H4M 2X6, CA
IndustryBiotechnology
CEOJoseph G. Oliveto

Key Management of Milestone Pharmaceuticals

Name

Title

Mr. Joseph G. Oliveto M.B.A.

CEO, President & Executive Director

Mr. Amit Hasija

CFO & Executive VP of Corporate Development

Dr. David B. Bharucha FACC, M.D., Ph.D.

Chief Medical Officer

Dr. Philippe Douville M.B.A., Ph.D.

Founder, Strategic Advisor & Member of Scientific Advisory Board

Mr. Jeff Moore

Vice President of Sales

Dr. Guy Rousseau

SVP of Regulatory Affairs and Quality Management

Mr. Jeffrey Nelson

Chief Operating Officer

Mr. David Sandoval

General Counsel & Chief Compliance Officer

Mr. Roshan Girglani

Vice President of Marketing

Dr. Philip T. Sager FACC, FAHA, FHRS, M.D.

Chief Medical Advisor & Member of the Scientific Advisory Board

FAQs

What is Milestone Pharmaceuticals share price today?

Milestone Pharmaceuticals share price today is $0.78 as on at the close of the market. Milestone Pharmaceuticals share today touched a day high of $0.82 and a low of $0.77.

What is the 52 week high and 52 week low for Milestone Pharmaceuticals share?

Milestone Pharmaceuticals share touched a 52 week high of $3.06 on and a 52 week low of $0.75 on . Milestone Pharmaceuticals stock price today i.e. is closed at $0.78,which is 74.53% down from its 52 week high and 3.63% up from its 52 week low.

What is Milestone Pharmaceuticals's market capitalisation today?

Milestone Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Milestone Pharmaceuticals Stock (MIST) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Milestone Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Milestone Pharmaceuticals Stock (MIST) from India?

Indian investors can start investing in Milestone Pharmaceuticals (MIST) shares with as little as ₹96.292503356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹962.93 in Milestone Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Milestone Pharmaceuticals share’s latest price of $0.78 as on October 6, 2026 at 8:46 am IST, you will get 12.8304 shares of Milestone Pharmaceuticals. Learn more about fractional shares .

What are the returns that Milestone Pharmaceuticals has given to Indian investors in the last 5 years?

Milestone Pharmaceuticals stock has given -86.4% share price returns and 29.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?